U.S. markets closed
  • S&P 500

    3,719.04
    +71.75 (+1.97%)
     
  • Dow 30

    29,683.74
    +548.75 (+1.88%)
     
  • Nasdaq

    11,051.64
    +222.13 (+2.05%)
     
  • Russell 2000

    1,715.24
    +52.73 (+3.17%)
     
  • Crude Oil

    81.80
    -0.35 (-0.43%)
     
  • Gold

    1,666.70
    -3.30 (-0.20%)
     
  • Silver

    18.89
    +0.01 (+0.03%)
     
  • EUR/USD

    0.9728
    +0.0130 (+1.35%)
     
  • 10-Yr Bond

    3.7050
    -0.2590 (-6.53%)
     
  • GBP/USD

    1.0865
    +0.0134 (+1.25%)
     
  • USD/JPY

    144.2290
    -0.5620 (-0.39%)
     
  • BTC-USD

    19,554.68
    +500.33 (+2.63%)
     
  • CMC Crypto 200

    447.10
    +18.32 (+4.27%)
     
  • FTSE 100

    7,005.39
    +20.80 (+0.30%)
     
  • Nikkei 225

    26,173.98
    -397.89 (-1.50%)
     

Ginkgo Bioworks Announces Date of Second Quarter 2022 Results Presentation

·1 min read

Presentation and Q&A session scheduled for post-market on Monday, August 15, 2022

BOSTON, Aug. 8, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2022, on Monday, August 15, 2022, beginning at 4:30 p.m. ET.

(PRNewsfoto/Ginkgo Bioworks)
(PRNewsfoto/Ginkgo Bioworks)

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com     

MEDIA CONTACT:

press@ginkgobioworks.com

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2022-results-presentation-301601471.html

SOURCE Ginkgo Bioworks